Comment on Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone. Int. J. Neonatal Screen. 2023, 9, 66
- PMID: 39449353
- PMCID: PMC11503260
- DOI: 10.3390/ijns10040065
Comment on Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone. Int. J. Neonatal Screen. 2023, 9, 66
Abstract
The assessment of newborn screening (NBS) algorithms' performance to ensure quality improvements is a continuous process: false-positive referrals can enable optimisations in the shorter term, but false-negative referrals are often only discovered many years after the screening has taken place [...].
Conflict of interest statement
The authors declare no conflicts of interest.
Comment on
- Int J Neonatal Screen. 9:66.
References
-
- Dijkstra A.M., Evers-van Vliet K., Heiner-Fokkema M.R., Bodewes F.A.J.A., Bos D.K., Zsiros J., van Aerde K.J., Koop K., van Spronsen F.J., Lubout C.M.A. A False-Negative Newborn Screen for Tyrosinemia Type 1—Need for Re-Evaluation of Newborn Screening with Succinylacetone. Int. J. Neonatal Screen. 2023;9:66. doi: 10.3390/ijns9040066. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous